CGTX- Cognition Therapeutics Inc

CGTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ricciardi Lisa	1.01M	$1.09M	-
Other	Caggiano Anthony	508.0K	$548.6K	-
CFO	Doyle John Brendan	446.0K	$481.7K	-
Dir	Wallace Peggy	111.5K	$120.4K	-
Dir	Richstone Ellen B	83.5K	$90.2K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 15, 2022	Wallace Peggy	Director	Buy	12,500	$1.20	$15,000.00	+49.1%	+24.8%	-27.6%
Oct 13, 2021	Golden Seeds Cognition Therapeutics LLC	10% Owner	Sell	33	$12.00	$397.08	-	-43.4%	-85.1%
Oct 13, 2021	Breedlove Mark H.	Director	Sell	12	$12.00	$140.88	-	-43.4%	-85.1%
Oct 13, 2021	Bios Memory Spv I, LP	10% Owner	Sell	90	$12.00	$1,083.36	-	-43.4%	-85.1%
Oct 13, 2021	Fletcher Aaron G.L.54	Director	Sell	90	$12.00	$1,083.36	-	-43.4%	-85.1%
Oct 13, 2021	Ogden Cap Associates, LLC	10% Owner	Sell	74	$12.00	$888.60	-	-43.4%	-85.1%
Oct 13, 2021	Bios Memory Spv I, LP	10% Owner	Buy	190,000	$12.00	$2,280,000.00	+22.2%	-43.4%	-85.1%
Oct 13, 2021	Fletcher Aaron G.L.54	Director	Buy	190,000	$12.00	$2,280,000.00	+22.2%	-43.4%	-85.1%
Oct 13, 2021	Wallace Peggy	Director	Buy	3,000	$12.00	$36,000.00	New	-43.4%	-85.1%
Oct 13, 2021	Ricciardi Lisa	CEO &President	Buy	12,500	$12.00	$150,000.00	New	-43.4%	-85.1%